期刊文献+

红细胞作为吗啡载体延长吗啡镇痛时效的研究(英文) 被引量:4

Study of Erythrocyte as Carrier to Prolong Action Duration of Morphine
下载PDF
导出
摘要 探讨用高渗法制备红细胞包蔽吗啡溶液(RBC-M)的可行性,对RBC-M制备过程中红细胞(RBC)的体积和形态的变化、RBC-M溶液内外的吗啡(M)浓度及含量的变化以及择期上腹部手术患者应用RBC-M溶液术后镇痛的时效和吗啡的血药浓度进行了研究.研究发现:(1)用高渗法制备红细胞包蔽吗啡溶液是可行的.(2)RBC-M溶液与单纯M溶液相比其术后镇痛作用显著延长;其药代动力学指标消除半衰期(T1/2)延长3倍多,曲线下面积(AUC0→∞)增加约11倍,而清除率(CL)明显减小约9倍.(3)用RBC-M溶液行术后镇痛的患者其时效明显优于单纯用吗啡的患者. In order to study the feasibility of using intact erythrocytes (RBCs) as morphine (M) carriers to prolong its duration of action in vivo, we investigated the changes on the total volume and the shapes of RBCs during the process of preparing RBC-M solutions, the concentrations of morphine both inside and outside the RBCs, as well as the clinical analgesic effects and pharmacokinetic parameters of RBC-M solutions in patients undergoing selective upper abdominal surgeries. We found that: (1) ideal RBC-M solutions with a high encapsulating rate could be obtained by hyperosmotic method, (2) compared with plain morphine solution, the RBC-M solution had a long potent.duration as postoperative analgesia and its T1/2, AUC0→∞ were longer; CL was significantly decreased, (3) The VAS in postoperative 24 h was significantly lower in group RBC-M than that in group M.
出处 《南京大学学报(自然科学版)》 CAS CSCD 北大核心 2003年第5期547-553,共7页 Journal of Nanjing University(Natural Science)
基金 Foundation Item:Jiangsu Society Development Foundation(BS2000056)
关键词 吗啡 镇痛时效 红细胞 药物载体 药代动力学 药效学 红细胞包蔽吗啡溶液 高渗法 erythrocytes, carrier, encapsulation, morphine, analgesia, pharmacokinetics
  • 相关文献

参考文献12

  • 1Deloach J R, Corrier D E. Subeutanoous administration of carrier erythrocytes: Slow release of entrapped agent. Biotechnological Application Biochemistry, 1988,10- 359 - 364.
  • 2Retting M, Low P S, Gimm A, et al. Evalution of biochemical changes during in vivo erythrocyte aenescence in the dog. Blood, 1999,93:376-384.
  • 3Naqi A, DeLoach J R, Andrews K, et al. Determination of parameters for eaazyme therapy using L-asparaginase entrapped in canine erythrocytes. Biotechnological Application Biochemistry, 1988, 10(4) :365 - 372.
  • 4Lotero L A, Olmos G, Diez J C. Delivery to macrophages and toxic action of etoposide carried in moase red blood cells. Biochimical Biophys Aeta, 2003, 17, 1 620(1-3) :160-166.
  • 5Pitt E, Johnson C M, Lewi D A. Encapsulation of drugs in intact erythrocytes on intravenous delivery system. Biochemical Pharmacology, 1983,32:3 359-3 364.
  • 6Muzykantov V R, Zasltsman A B,Smirnov M D, et al. Target-sensitive immunoerythrocytes: Interaction of biotinylated red blood cells with immobilized avidin induces their lysis by complement. Biochimical Biophysical Acta, 1996,1279: 137.
  • 7Ronald D, Miller A. Harcourt Asia Churchill. 5^th Edition. Livingstone:Science Press,2001, 1:2 324-2 325.
  • 8Garin M I, Lopez R M. Erythrocytes as carriers for recombinant hum erythropoietin. Pharmcological Research, 1996,13:869-882.
  • 9Hamarat B S, Uslan A H. Encapsulatioa by hypotonic dialysis in human erythrocytes: A diffusion or endocytosis process. Biotechnological Application Biochemistry, 1991, 13(1):72-82.
  • 10Bax B E, Bain M D. In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-cojugated and native adenosine deaminase. British-Jounary-Haematol, 2000, 109(3) : 549-594.

同被引文献24

  • 1纪立伟.药物剂型知识系列介绍(2) 缓释制剂与控释制剂[J].中国临床医生杂志,2005,33(6):39-40. 被引量:2
  • 2骆璇,汪小海,徐鑫,崔苏扬,徐福涛.冠脉搭桥术病人红细胞包蔽吗啡溶液术后镇痛的可行性[J].中华麻醉学杂志,2005,25(6):410-413. 被引量:2
  • 3Bruera E,Sala R,Spruyt O,el al.Nebulized versus subcutaneous morphine for patients with cancer dyspnea:A preliminary study.Journal of Pain and Symptom Management,2005,29(6):613-618.
  • 4Brown S J,Eichner S F,Jones J R Nebulized morphine for relief of dyspnea due to chronic lung disease.Annals of Pharmacotherapy.2005,39(6):1088-1092.
  • 5Fulda G J,Giberson F,Fagraeus L A prospective randomized trial of nebulized morphine compared with patient-controlled analgesia morphine in the management of acute thoracic pain.Journal of Trauma,2005,59(2):383-388,discussion 389-390.
  • 6Selami Atesonal,Erol Keles,Gonca Caglar To prak,et al.Preliminary findings for preemptive analgesia with inhaled morphine:Efficacy in septoplasty and septorhinoplasty cases.Otolaryngology-Head and Neck Surgery,2006,135(1):85-89.
  • 7Chrubasik J,Wust H,Friedrieh G,et al.Absorption and bioavailability of nebulized morphine.British Journal of Anaesthesia,1988,61(2):228-230.
  • 8Masood A R,Thomas S H.Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects.British Journal of Clinical Pharmacology,1996,41(3):250-252.
  • 9Ward M E,Woodhouse A,Mather L E,et al.Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system.Clinical Pharmacological Therapeutics,1997,62(6):596-609.
  • 10Dershwitz M,Walsh J L,Morishige R J,et al.Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers.Anesthesiology,2000,93(3):619-628.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部